414 related articles for article (PubMed ID: 15494840)
1. Typhoid fever due to multiresistant Salmonella enterica serovar typhi having reduced susceptibility to ciprofloxacin and nalidixic acid resistance.
Panhotra BR; Saxena AK; Al-Ghamdi AM
Saudi Med J; 2004 Oct; 25(10):1509-11. PubMed ID: 15494840
[No Abstract] [Full Text] [Related]
2. Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh.
Asna SM; Haq JA; Rahman MM
Jpn J Infect Dis; 2003 Feb; 56(1):32-3. PubMed ID: 12711825
[No Abstract] [Full Text] [Related]
3. Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon.
Nkemngu NJ; Asonganyi ED; Njunda AL
BMC Infect Dis; 2005 Jun; 5():49. PubMed ID: 15969764
[TBL] [Abstract][Full Text] [Related]
4. Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin--an emerging problem in Bangladesh.
Rahman MM; Haq JA; Morshed MA; Rahman MA
Int J Antimicrob Agents; 2005 Apr; 25(4):345-6. PubMed ID: 15784317
[No Abstract] [Full Text] [Related]
5. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.
Kadhiravan T; Wig N; Kapil A; Kabra SK; Renuka K; Misra A
BMC Infect Dis; 2005 May; 5():37. PubMed ID: 15904505
[TBL] [Abstract][Full Text] [Related]
7. [A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Gaborieau V; Weill FX; Marchou B
Med Mal Infect; 2010 Dec; 40(12):691-5. PubMed ID: 20724089
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant Salmonella enterica serovar typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh.
Ahmed D; D'Costa LT; Alam K; Nair GB; Hossain MA
Antimicrob Agents Chemother; 2006 Oct; 50(10):3516-7. PubMed ID: 17005846
[No Abstract] [Full Text] [Related]
9. Low-level quinolone-resistance in multi-drug resistant typhoid.
Mirza SH; Khan MA
J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
[TBL] [Abstract][Full Text] [Related]
10. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia.
Kasper MR; Sokhal B; Blair PJ; Wierzba TF; Putnam SD
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):207-9. PubMed ID: 19800753
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility patterns of Salmonella enterica serotype typhi in eastern Nepal.
Khanal B; Sharma SK; Bhattacharya SK; Bhattarai NR; Deb M; Kanungo R
J Health Popul Nutr; 2007 Mar; 25(1):82-7. PubMed ID: 17615907
[TBL] [Abstract][Full Text] [Related]
12. Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
Ciraj AM; Seema DS; Bhat GK; Shivananda PG
Indian J Pathol Microbiol; 2001 Oct; 44(4):407-8. PubMed ID: 12035350
[No Abstract] [Full Text] [Related]
13. Typhoid fever: narrowing therapeutic options in India.
Capoor MR; Nair D; Hasan AS; Aggarwal P; Gupta B
Southeast Asian J Trop Med Public Health; 2006 Nov; 37(6):1170-4. PubMed ID: 17333772
[TBL] [Abstract][Full Text] [Related]
14. Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi.
Rupali P; Abraham OC; Jesudason MV; John TJ; Zachariah A; Sivaram S; Mathai D
Diagn Microbiol Infect Dis; 2004 May; 49(1):1-3. PubMed ID: 15135492
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
Menezes GA; Harish BN; Khan MA; Goessens WH; Hays JP
Clin Microbiol Infect; 2012 Mar; 18(3):239-45. PubMed ID: 21714829
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
17. High level of resistance to nalidixic acid in Salmonella enterica serovar Typhi in Central India.
Kumar Y; Sharma A; Mani KR
J Infect Dev Ctries; 2009 Jul; 3(6):467-9. PubMed ID: 19762961
[TBL] [Abstract][Full Text] [Related]
18. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
[TBL] [Abstract][Full Text] [Related]
19. Scattergram analysis to explore the emerging problem related to in vitro susceptibility test for Salmonella enterica serovar Typhi to ciprofloxacin.
Pal NK; Mandal S; Mandal MD
Int J Antimicrob Agents; 2004 Sep; 24(3):297-9. PubMed ID: 15325437
[TBL] [Abstract][Full Text] [Related]
20. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006.
Mengo DM; Kariuki S; Muigai A; Revathi G
J Infect Dev Ctries; 2010 Jun; 4(6):393-6. PubMed ID: 20601792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
